New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory epithelium inflammatio

Discussion in 'Mast Cell Disorders/Mastocytosis' started by osisposis, Jul 25, 2016.

  1. osisposis

    osisposis Senior Member

    Messages:
    389
    Likes:
    231
    Cathelicidin (LL-37) is an endogenous innate immune peptide that is elevated in patients with chronic rhinosinusitis (CRS). The role of LL-37 in olfactory epithelium (OE) inflammation remains unknown. We hypothesized that: (1) LL-37 topically delivered would elicit profound OE inflammation; and (2) LL-37 induced inflammation is associated with increased infiltration of neutrophils and mast cells.

    LL-37 has dramatic inflammatory effects in the OE mucosa that is dose-dependent. The observed inflammatory changes in the olfactory mucosa were associated with the infiltration of both neutrophils and mast cells. Our biologic model represents a new model to further investigate the role of LL-37 in OE inflammation.

    http://www.ncbi.nlm.nih.gov/pubmed/26346056
     

See more popular forum discussions.

Share This Page